The Vanguard Group 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Kura Oncology, Inc. KURA |
The Vanguard Group | 4,037,691 5.440% |
632,522 (+18.58%) |
Filing |
| 2023-02-09 11:25 am Purchase |
2022-12-30 | 13G | Kura Oncology, Inc. KURA |
The Vanguard Group | 3,405,169 5.090% |
3,405,169 (New Position) |
Filing |